Therapy of hepatocellular cancer with iodine-131-Lipiodol.
Most patients with hepatocellular carcinoma are not eligible for surgery at the time of primary diagnosis. Portal vein thrombosis is frequent and represents a contraindication for transarterial chemoembolisation. Transarterial therapy with iodine-131-Lipiodol is superior to systemic therapy in tumours up to diameters of 5 cm and may be performed even in cases with portal vein thrombosis. Compared to other intraarterial therapy procedures, iodine-131-Lipiodol shows the same efficacy but less side effects.
Risse
Jörn H
JH
Radiology and Nuclear Medicine Institute, von-Stauffenberg-Str. 9, D - 56304 Bad Honnef, Germany. Joern.Risse@freenet.de
Menzel
Christian
C
Grünwald
Frank
F
Strunk
Holger
H
Biersack
Hans-Jürgen
HJ
Palmedo
Holger
H
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D004338:Drug Combinations; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use*; D007459:Iodized Oil / Q000008:administration & dosage / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D004338:Drug Combinations; D007457:Iodine Radioisotopes; D007459:Iodized Oil